Collective Insanity.
Why Your Health Insurer Is Reading Your Tweets
Change This – Art Is Freedom
I believe Art represents the extraordinary form of genetic talent each of us are born with, as well as the ongoing fuel to declare this distinct expression every day. The nature of this primitive desire is so strong that when we use our artistic capacity we feel a strange empowering sense of completeness, of being at home within ourselves. You start to crave more of it, realizing this task is the single thing that makes you feel truly alive.
Acetaminophen: Drug Safety Communication – Association with Risk of Serious Skin Reactions
FDA notified healthcare professionals and patients that acetaminophen has been associated with a risk of rare but serious skin reactions. Acetaminophen is a common active ingredient to treat pain and reduce fever; it is included in many prescription and over-the-counter (OTC) products. These skin reactions, known as Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), and acute generalized exanthematous pustulosis (AGEP), can be fatal.
via Safety Alerts for Human Medical Products > Acetaminophen: Drug Safety Communication – Association
Yikes!
Leaving the Nest – NOT
As the Federal Reserve considers weaning the nation from financial life support, a new study released Thursday by Pew Research Center shows that the number of young adults living with their parents in 2012 rose to a record 36%.
via For millennials, leaving the nest is hard to do – latimes.com.
A Lost Generation | Thoughts from the Frontline Investment Newsletter | Mauldin Economics
An Ugly Secular Trend in Part-Time Work
via A Lost Generation | Thoughts from the Frontline Investment Newsletter | Mauldin Economics.
It’s been a while since I posted a link to some Scary Charts. You want Scary Charts? Read this online post and you’ll see plenty of Scary Charts.
Standardizing ABI Measurements & Interpretations | Physician’s Weekly
When the ankle-brachial index (ABI) emerged in 1950, it was initially proposed for use as a noninvasive diagnostic tool for lower-extremity peripheral artery disease (PAD). Since then, studies have shown that the ABI is an indicator of atherosclerosis at other vascular sites, making it a useful prognostic marker for cardiovascular events and functional impairment, even in the absence of symptoms of PAD.
via Standardizing ABI Measurements & Interpretations | Physician’s Weekly.
Patients Average C+ on Drug Compliance – amednews.com
The two diseases with the highest avoidable noncompliance costs are hypercholesterolemia $44 billion and diabetes $24.6 billion, the study found.
via Patients average only C+ on drug compliance – amednews.com.
Race Has Role in Vitamin D Link to Heart Risk
A 10-ng/mL decrease in 25(OH)D levels was associated with an increased risk of coronary heart disease events in whites (HR 1.26, 95% CI 1.06-1.49) and those with Chinese ancestry (HR 1.67, 95% CI 1.07-2.61), according to Ian de Boer, MD, of the University of Washington in Seattle, and colleagues.
But a similar relationship was not seen among blacks (HR 0.93, 95% CI 0.73-1.20) and Hispanics (HR 1.01, 95% CI 0.77-1.33), the investigators reported in the July 10 issue of the Journal of the American Medical Association.
via Race Has Role in Vitamin D Link to Heart Risk.
A couple of years ago I asked my primary care physician to check my Vitamin D level. We were both surprised to discover the fact I was Vitamin D deficient. Since then I’ve been on daily Vitamin D supplementation of 5000iu.
Simple blood test. Just do it.
The researchers advised caution in interpreting the results in the Chinese and Hispanic participants because of the low sample sizes.
I’m still going to take my supplement.
Large Study Affirms Safety of Statins
The study included information from 135 randomized trials — 55 with a placebo control and 80 with an active comparator — that included a total of 246,955 participants with or without cardiovascular disease. The study initially included trials of atorvastatin, fluvastatin, simvastatin, lovastatin, pravastatin, and rosuvastatin (Crestor); trials of pitavastatin (Livalo) were added post hoc because the protocol was already being finalized at the time the drug was approved.
You must be logged in to post a comment.